The global nano satellite report published
by BIS Research highlights the market dynamics which includes market drivers,
challenges and restraints prevalent, and the potential opportunities available
in the market. Key strategies such as partnerships, agreements, and contracts,
product launches, and mergers and acquisitions adopted by leading players in
the market are also discussed in the study. For the ease of understanding, the
report identifies the nano satellite market under different segments namely,
mass, subsystem, application, end user, and region.
Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Comments
Post a Comment